Cylindromatosis (CYLD) inhibits Streptococcus pneumonia-induced plasminogen activator inhibitor-1 expression via
1Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Abstract:
Streptococcus pneumoniae (S. p) remains one of the foremost causes of community-acquired pneumonia. Recent studies have shown that S. p lung infection is associated with plasminogen activator inhibitor-1 (PAI-1) expression, which inhibits acute lung injury. Such effects by S. p were negatively regulated by cylindromatosis (CYLD). The current study explored the underlying mechanisms. We showed that S. p-induced PAI-1 expression requires tumor necrosis factor receptor-associated factor 6 (TRAF-6) signaling. Si-RNA-mediated knockdown of TRAF-6 remarkably inhibited S. p-induced PAI-1 expression. Reversely, over-expression of wild type (wt-) TRAF-6 further potentiated PAI-1 expression in S. p-treated cells. We provided evidences to support that CYLD-mediated anti-PAI-1 activity might be through direct regulation of TRAF-6. Our results from co-immunoprecipitation (co-IP) and confocal microscopy assays confirmed a direct association between the CYLD and TRAF-6 in A549 cells. Over-expression of wt-CYLD remarkably inhibited TRAF-6 ubiquitination and subsequent PAI-1 expression. Introducing a mutated CYLD, on the other hand, enhanced TRAF-6 ubiquitination and PAI-1 expression. Together, these results indicate that TRAF-6 mediates S. p-induced PAI-1 expression, and CYLD inhibits PAI-1 expression probably through deubiquitinating TRAF-6. The current study provided molecular insights of CYLD-mediated activities in S. p-induced PAI-1 expression and possible acute lung injury.
Insights
Streptococcus pneumoniae (S. pneumoniae) lung infections involve plasminogen activator inhibitor-1 (PAI-1), regulated by cylindromatosis (CYLD). CYLD inhibits PAI-1 by deubiquitinating tumor necrosis factor receptor-associated factor 6 (TRAF-6).
Area of Science:
- Immunology
- Molecular Biology
- Pulmonology
Background:
- Streptococcus pneumoniae (S. pneumoniae) is a leading cause of community-acquired pneumonia.
- S. pneumoniae infection is linked to plasminogen activator inhibitor-1 (PAI-1) expression, which mitigates acute lung injury.
- Cylindromatosis (CYLD) negatively regulates S. pneumoniae-induced PAI-1 effects.
Purpose of the Study:
- To elucidate the molecular mechanisms by which CYLD regulates S. pneumoniae-induced PAI-1 expression.
- To investigate the role of tumor necrosis factor receptor-associated factor 6 (TRAF-6) signaling in this pathway.
Main Methods:
- Si-RNA mediated knockdown of TRAF-6.
- Over-expression of wild-type (wt-) and mutated CYLD and TRAF-6.
- Co-immunoprecipitation (co-IP) assays.
- Confocal microscopy.
Main Results:
- S. pneumoniae-induced PAI-1 expression is dependent on TRAF-6 signaling.
- Knockdown of TRAF-6 significantly inhibited S. pneumoniae-induced PAI-1 expression.
- CYLD directly associates with TRAF-6.
- Over-expression of wt-CYLD inhibited TRAF-6 ubiquitination and PAI-1 expression, while mutated CYLD enhanced it.
Conclusions:
- TRAF-6 mediates S. pneumoniae-induced PAI-1 expression.
- CYLD inhibits PAI-1 expression by deubiquitinating TRAF-6.
- These findings offer molecular insights into CYLD's role in S. pneumoniae-induced PAI-1 expression and potential acute lung injury modulation.
More Related Videos
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Intracellular Signaling Affects Focal Adhesions
Some...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...


